Nanoform’s Post

In a newly published article on Bioprocess International's Featured Report on Antibody Drug Conjugates (ADCs), it discusses how WuXi XDC, with the inherent challenges of ADC development, built a one-stop CRDMO solution that simplifies discovery and CMC development of bioconjugates to drive efficiencies and reduce time to clinic. To read the full article, please visit: https://lnkd.in/epeUdzyj #bioconjugation #antibodydisocvery #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #antibodydrugconjugate

#CaseStudy A customer approached Enzene to help overcome an upstream batch bottleneck for their human-engineered #mAb product, which currently was not viable for more than 10 days. In addition, no established purification steps were in place. The development of an effective manufacturing method was made harder by the instability of the mAb product. Want to know more about this case study? Read the full case study here 👉 https://lnkd.in/daBCMM9r #biologics

Day one at the WADC next generation conjugates summit. Great to hear and connect with all the innovators in the ADC space - not just ADCs but on siRNA, miRNA conjugates…… Curia supports all these innovations with our end-to-end ADC discovery capability from ADC matrix discovery, custom payload optimization, ADC bioassay and bioanalytical assay, analytics for ADC etc. We support ADC development and CMC. please stop by our poster or discuss with us on ADC generation and how to bring your biologics to ADC. We support both potent and non-potent bioconjugates. #adc #bioconjugation #biologics #antibodies #antibodydrugconjugates #aoc #radiopharmaceuticals #theranostics #AOC #nextgenerationconjugates

Watch as Alex Lemons shares his insights on the Ventana interbody family, the vital role of biologics in the race to fusion and the importance of maximizing biologics within 3D-printed interbodies. Watch Part 1 “Race to Fusion” here: https://bit.ly/48dAQWB #ventana #spinalelements #3dprinted #spinalfusion #biologics

If you are struggling with viability for your mAbs, you might find this case study helpful. Reach out if you have problems with low titer, etc as well.

We have published the 2024 Biologics and Advanced Therapies Contract Manufacturing Report, offering a comprehensive analysis of current industry trends and competitive dynamics across North America and Europe. Download it here: https://lnkd.in/gtRrqUAt This annual report provides key insights into the challenges and opportunities facing the biologics and advanced therapies contract development and manufacturing organization market as it navigates macro-economic uncertainty. See our expert commentary on the report findings from Carlo S. below and read the full press release: https://lnkd.in/gf6PApAu Connect with the authors to learn more: Filippo Pendin, Mololuwa Oluwajobi, and Carlo S.. #CDMObiologics #biologics #ATMP #advancedtherapies

Really insightful presentations today at the 2024 Revvity Summit: Advanced Tools for Biologics Development! Huge thank you to our incredible guest speakers for coming to share insights from their research! #RevvitySummit #Biologics #RevvUpResearch

Every biologic starts with a plasmid. Plasmids are the backbone of life-saving therapies. Learn how to speed plasmid discovery and scale plasmid development: https://bit.ly/3yTbOOR #DanaherLifeSciences #pDNA #plasmid #vector #biologics #genetherapy